Please ensure Javascript is enabled for purposes of website accessibility

Why Canopy Growth, Organigram Holdings, and HEXO Shares Jumped Tuesday

By Howard Smith - Mar 9, 2021 at 12:52PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Stocks of the Canadian pot growers are reversing a recent downtrend today.

What happened

It's been a down month for Canadian cannabis stocks like Canopy Growth (CGC -5.96%), Organigram Holdings (OGI -3.20%), and HEXO (HEXO -5.11%). These stocks have had several catalysts influencing them with both political and company-specific news. 

Shares are bouncing today, with Canopy Growth up 6.3%, Organigram up 3.5%, and HEXO up 4.8%, as of 11:20 a.m. EST.

So what

There are no new announcements from the companies today. But after shares have dropped between 35% and 50% in just the past month, some recent progress with new product offerings, and legalization expanding among U.S. states, investors are feeling like buying the dip today. 

CGC Chart

CGC data by YCharts

Canopy Growth recently announced its entrance into the U.S. CBD beverage market, and has been growing sponsorship for its majority owned BioSteel sports nutrition brand. Last week, Organigram announced the launch of two new products in its recreational cannabis product portfolio. 

marijuana buds in jars at dispensary

Image source: Getty Images.

Now what

Canopy Growth has a big investor in beverage company Constellation Brands (STZ -0.14%). Constellation has even added to its initial $4 billion investment in the pot company. That partnership helps provide Canopy a distribution framework in the U.S. So when it announced the launch of its Quatreau CBD beverage brand in the U.S. last week, it seemed very complementary. The company calls the Quatreau brand "a premium ready-to-drink CBD-infused sparkling water." Quatreau has grown to become Canada's top-selling ready-to-drink CBD beverage, according to Canopy Growth. 

Canopy also announced last week that NBA star Luka Doncic will join the CBD-based sports nutrition product maker BioSteel with the title of "global chief hydration officer." Canopy purchased a majority stake in BioSteel in 2019. 

These moves into U.S. products set up Canopy in the event that federal marijuana legalization eventually allows the company to participate in that market with THC-based products. Progress on the state level continued when Virginia became the 16th U.S. state to approve marijuana legalization for adult recreational use two weeks ago (adult recreational use is also legal in the District of Columbia). Gov. Ralph Northam still needs to sign the bill, but he supports legalization, which will allow for sales to begin in 2024.

Organigram's new "Jar of Joints" and "Trailblazer SNAX Milk Chocolate Bars" contain THC so are not available in the U.S. at this point. But both Organigram and HEXO would be beneficiaries of any progress toward federal legalization in the U.S. 

Investors watched the stocks correct significantly in the past month, and the potential growth both inside and outside of Canada has some investors taking the opportunity to buy today. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Stock Quote
Canopy Growth
CGC
$5.52 (-5.96%) $0.35
Constellation Brands, Inc. Stock Quote
Constellation Brands, Inc.
STZ
$234.50 (-0.14%) $0.33
OrganiGram Holdings Stock Quote
OrganiGram Holdings
OGI
$1.21 (-3.20%) $0.04
HEXO Stock Quote
HEXO
HEXO
$0.28 (-5.11%) $0.02

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
331%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/20/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.